Cargando…
PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients
BACKGROUND/AIM: Hepatocellular carcinoma (HCC) is one of the most common forms of liver cancer that is modulated by the immune system. Programmed cell death ligand-1 (PD-L1) has emerged as a novel therapeutic target in various cancers. Indoleamine 2,3-dioxygenase (IDO) is an immunosuppressive enzyme...
Autores principales: | Asghar, Kashif, Bashir, Shaarif, Ali Rana, Iftikhar, Abu Bakar, Muhammad, Farooq, Asim, Hassan, Muhammad, Asif, Zukhruf, Afzal, Mahnoor, Masood, Iqra, Ishaq, Muhammad, Tahseen, Muhammad, Bilal, Sundus, Mehmood, Shafqat, Kanwal, Nosheen, Ud Din, Islah, Loya, Asif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284167/ https://www.ncbi.nlm.nih.gov/pubmed/37350801 http://dx.doi.org/10.2147/JHC.S409741 |
Ejemplares similares
-
Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan
por: Asghar, Kashif, et al.
Publicado: (2019) -
High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients
por: Asghar, Kashif, et al.
Publicado: (2023) -
Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients
por: Asghar, Kashif, et al.
Publicado: (2020) -
Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan
por: Asghar, Kashif, et al.
Publicado: (2019) -
Relapse of Non-Gastrointestinal Langerhans Cell Histiocytosis in the Rectum
in a Child: A Case Report
por: Saeed, Saad Muhammad, et al.
Publicado: (2023)